dc.contributor.author |
Habte, Habtom H
|
en_ZA |
dc.contributor.author |
Mall, Anwar S
|
en_ZA |
dc.contributor.author |
de Beer, Corena
|
en_ZA |
dc.contributor.author |
Lotz E, Zoe
|
en_ZA |
dc.contributor.author |
Kahn, Delawir
|
en_ZA |
dc.date.accessioned |
2015-10-28T07:09:55Z |
|
dc.date.available |
2015-10-28T07:09:55Z |
|
dc.date.issued |
2006 |
en_ZA |
dc.identifier.citation |
Habte, H. H., Mall, A. S., De Beer, C., Lotz, Z. E., & Kahn, D. (2006). The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay. Virol Journal, 3(24), 99. |
en_ZA |
dc.identifier.uri |
http://hdl.handle.net/11427/14489
|
|
dc.identifier.uri |
http://dx.doi.org/10.1186/1743-422X-3-99
|
|
dc.description.abstract |
BACKGROUND: Despite the continuous shedding of HIV infected blood into the oral cavity and the detectable presence of the AIDS virus at a high frequency, human saliva is reported to inhibit oral transmission of HIV through kissing, dental treatment, biting, and aerosolization. The purpose of this study was to purify salivary MUC5B and MUC7 mucins from crude saliva and determine their anti-HIV-1 activities. METHODS: Following Sepharose CL-4B column chromatography and caesium chloride isopycnic density-gradient ultra-centrifugation, the purity and identity of the mucins was determined by SDS-PAGE and Western blotting analysis respectively. Subsequently an HIV-1 inhibition assay was carried out to determine the anti-HIV-1 activity of the crude saliva and purified salivary mucins by incubating them with subtype D HIV-1 prior to infection of the CD4+ CEM SS cells. RESULTS: Western blotting analysis confirmed that the mucin in the void volume is MUC5B and the mucin in the included volume is MUC7. The HIV inhibition assay revealed that both the crude saliva and salivary MUC5B and MUC7 mucins inhibited HIV-1 activity by 100%. CONCLUSION: Although the mechanism of action is not clear the carbohydrate moieties of the salivary mucins may trap or aggregate the virus and prevent host cell entry. |
en_ZA |
dc.language.iso |
eng |
en_ZA |
dc.publisher |
BioMed Central Ltd |
en_ZA |
dc.rights |
This is an Open Access article distributed under the terms of the Creative Commons Attribution License |
en_ZA |
dc.rights.uri |
http://creativecommons.org/licenses/by/2.0 |
en_ZA |
dc.source |
Virology Journal |
en_ZA |
dc.source.uri |
http://www.virologyj.com/
|
en_ZA |
dc.subject.other |
Human saliva, HIV transmission, HIV (Viruses), Oral transmission, HIV (Viruses) Research |
en_ZA |
dc.title |
The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay |
en_ZA |
dc.type |
Journal Article |
en_ZA |
dc.rights.holder |
2006 Habte et al; licensee BioMed Central Ltd. |
en_ZA |
uct.type.publication |
Research |
en_ZA |
uct.type.resource |
Article
|
en_ZA |
dc.publisher.institution |
University of Cape Town |
|
dc.publisher.faculty |
Faculty of Health Sciences |
en_ZA |
dc.publisher.department |
Department of Surgery |
en_ZA |
uct.type.filetype |
Text |
|
uct.type.filetype |
Image |
|
dc.identifier.apacitation |
Habte, H. H., Mall, A. S., de Beer, C., Lotz E, Z., & Kahn, D. (2006). The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay. <i>Virology Journal</i>, http://hdl.handle.net/11427/14489 |
en_ZA |
dc.identifier.chicagocitation |
Habte, Habtom H, Anwar S Mall, Corena de Beer, Zoe Lotz E, and Delawir Kahn "The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay." <i>Virology Journal</i> (2006) http://hdl.handle.net/11427/14489 |
en_ZA |
dc.identifier.vancouvercitation |
Habte HH, Mall AS, de Beer C, Lotz E Z, Kahn D. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay. Virology Journal. 2006; http://hdl.handle.net/11427/14489. |
en_ZA |
dc.identifier.ris |
TY - Journal Article
AU - Habte, Habtom H
AU - Mall, Anwar S
AU - de Beer, Corena
AU - Lotz E, Zoe
AU - Kahn, Delawir
AB - BACKGROUND: Despite the continuous shedding of HIV infected blood into the oral cavity and the detectable presence of the AIDS virus at a high frequency, human saliva is reported to inhibit oral transmission of HIV through kissing, dental treatment, biting, and aerosolization. The purpose of this study was to purify salivary MUC5B and MUC7 mucins from crude saliva and determine their anti-HIV-1 activities. METHODS: Following Sepharose CL-4B column chromatography and caesium chloride isopycnic density-gradient ultra-centrifugation, the purity and identity of the mucins was determined by SDS-PAGE and Western blotting analysis respectively. Subsequently an HIV-1 inhibition assay was carried out to determine the anti-HIV-1 activity of the crude saliva and purified salivary mucins by incubating them with subtype D HIV-1 prior to infection of the CD4+ CEM SS cells. RESULTS: Western blotting analysis confirmed that the mucin in the void volume is MUC5B and the mucin in the included volume is MUC7. The HIV inhibition assay revealed that both the crude saliva and salivary MUC5B and MUC7 mucins inhibited HIV-1 activity by 100%. CONCLUSION: Although the mechanism of action is not clear the carbohydrate moieties of the salivary mucins may trap or aggregate the virus and prevent host cell entry.
DA - 2006
DB - OpenUCT
DO - 10.1186/1743-422X-3-99
DP - University of Cape Town
J1 - Virology Journal
LK - https://open.uct.ac.za
PB - University of Cape Town
PY - 2006
T1 - The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay
TI - The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay
UR - http://hdl.handle.net/11427/14489
ER -
|
en_ZA |